Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology

by Brian J. Miller, David R. Goldsmith
Published 2019-12-01

Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits

by David R. Goldsmith, Mark Hyman Rapaport
Published 2020-02-01

Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion

by Justin K. Ellis, Elaine F. Walker, David R. Goldsmith
Published 2020-09-01

The interaction of lipids and inflammatory markers predict negative symptom severity in patients with schizophrenia

by David R. Goldsmith, Nicholas Massa, Brian J. Miller, Andrew H. Miller, Erica Duncan
Published 2021-10-01

485 Investigating the Impact of Inflammation on White Matter Tracts using Diffusion Tensor Imaging that may Contribute to Motivational Deficits and Negative Symptoms in Patients wi...

by Nicholas Thomas, Courtney Ning, Robin E Gross, Tianwen Ma, Ebrahim Haroon, David R Goldsmith
Published 2024-04-01

Clinical and Structural Differences in Delusions Across Diagnoses: A Systematic Review

by Kelly Rootes-Murdy, Kelly Rootes-Murdy, David R. Goldsmith, Jessica A. Turner, Jessica A. Turner
Published 2022-01-01

Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects

by Bradley D. Pearce, Nicholas Massa, Nicholas Massa, David R. Goldsmith, Zeal H. Gandhi, Allison Hankus, Alaaeddin Alrohaibani, Neha Goel, Bruce Cuthbert, Bruce Cuthbert, Molly Fargotstein, Dana Boyd Barr, Parinya Panuwet, Victoria M. Brown, Erica Duncan, Erica Duncan
Published 2020-11-01